← All organizations
Siemens
For profit
Also known as: MEDICALI'S | PETNET | Siemens Corporation, Corporate Technology | Siemens Healthcare GmbH | Siemens Healthcare QT | Siemens Healthcare Sp. z o.o. | Siemens Healthineers | Siemens Healthineers AG | Siemens Healthineers, France | Siemens Healthineers Nederland B.V. | Siemens Medical Solutions | Siemens Medical Solutions USA - CSG | Varian, a Siemens Healthineers Company
Highest phase reached
Phase 3
Timeline
1840s
- Jan 1, 1847
Siemens— Founded
2000s
- Jan 1, 2006
Wallace & Tiernan— Acquired
2010s
- Feb 25, 2011
fludeoxyglucose f-18— Marketing Organization
Drugs by trial phase (12 distinct, 17 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carotid Stenosis
- Constriction, Pathologic
- Head and Neck Neoplasms
- Hypoxia
- Liver Neoplasms
- Lung Neoplasms
- Melanoma
- Prostatic Neoplasms
- Rectal Neoplasms
- Sarcoma
- Uterine Cervical Neoplasms
Marketed drugs (3)
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (17)
- NCT06087614CollaboratorPhase 2Oct 31, 2023
- NCT04316676CollaboratorN/AMay 31, 2020
- NCT04027556CollaboratorN/AJun 27, 2019
- NCT02659527CollaboratorPhase 3Jan 1, 2016
- NCT02652923CollaboratorPhase 1/Phase 2Jan 1, 2016
- NCT01506427Lead sponsorPhase 1/Phase 2Sep 1, 2012
- NCT01602471Lead sponsorPhase 2May 1, 2012
- NCT01362712Lead sponsorPhase 1May 1, 2011
- NCT01075399Lead sponsorPhase 2Feb 1, 2010
- NCT00988936Lead sponsorPhase 2Sep 1, 2009
- NCT00954369Lead sponsorEarly Phase 1Aug 1, 2009
- NCT01213030Lead sponsorPhase 1/Phase 2Jun 1, 2009
- NCT00884520Lead sponsorEarly Phase 1Apr 1, 2009
- NCT00847509Lead sponsorN/AFeb 1, 2009
- NCT00743353Lead sponsorEarly Phase 1Aug 1, 2008
Details
- Founded
- Berlin, DE Jan 1, 1847
- Last known activity
- Oct 31, 2023